Bath & Body Works, Inc. (NYSE:BBWI) Shares Purchased by DNB Asset Management AS
DNB Asset Management AS increased its holdings in Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) by 6.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 46,568 shares of the company’s stock after purchasing an additional 2,760 shares during the quarter. DNB Asset Management AS’s holdings in Bath & Body Works were worth $2,226,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of the business. Acadian Asset Management LLC acquired a new stake in shares of Bath & Body Works in the fourth quarter valued at about $30,000. Alpha Paradigm Partners LLC acquired a new position in shares of Bath & Body Works during the fourth quarter valued at approximately $40,000. CWM LLC purchased a new position in shares of Bath & Body Works in the fourth quarter valued at approximately $42,000. Signaturefd LLC boosted its stake in shares of Bath & Body Works by 72.4% in the fourth quarter. Signaturefd LLC now owns 693 shares of the company’s stock worth $48,000 after acquiring an additional 291 shares during the last quarter. Finally, Dark Forest Capital Management LP purchased a new position in Bath & Body Works in the 3rd quarter valued at $70,000. Institutional investors own 97.11% of the company’s stock.
In related news, CFO Wendy C. Arlin sold 6,000 shares of Bath & Body Works stock in a transaction that occurred on Tuesday, April 19th. The shares were sold at an average price of $55.00, for a total value of $330,000.00. Following the completion of the transaction, the chief financial officer now owns 98,888 shares in the company, valued at $5,438,840. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Thomas E. Mazurek sold 16,338 shares of the business’s stock in a transaction that occurred on Friday, May 27th. The stock was sold at an average price of $42.25, for a total transaction of $690,280.50. Following the transaction, the insider now owns 11,225 shares of the company’s stock, valued at approximately $474,256.25. The disclosure for this sale can be found here. 0.37% of the stock is currently owned by corporate insiders.
BBWI stock opened at $30.95 on Friday. The business’s fifty day moving average price is $43.50 and its 200 day moving average price is $52.00. Bath & Body Works, Inc. has a 12-month low of $28.89 and a 12-month high of $82.00. The company has a market capitalization of $7.08 billion, a PE ratio of 6.74, a P/E/G ratio of 0.90 and a beta of 1.58.
Bath & Body Works (NYSE:BBWI – Get Rating) last issued its quarterly earnings results on Wednesday, May 18th. The company reported $0.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.13. Bath & Body Works had a net margin of 15.41% and a negative return on equity of 69.03%. The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.43 billion. Sell-side analysts expect that Bath & Body Works, Inc. will post 4.01 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, June 17th. Shareholders of record on Friday, June 3rd were paid a $0.20 dividend. The ex-dividend date was Thursday, June 2nd. This represents a $0.80 annualized dividend and a dividend yield of 2.58%. Bath & Body Works’s dividend payout ratio (DPR) is 17.43%.
Several equities analysts have recently weighed in on the stock. Cowen decreased their price target on shares of Bath & Body Works from $82.00 to $60.00 and set an “outperform” rating on the stock in a research note on Friday, May 20th. BMO Capital Markets dropped their price target on Bath & Body Works from $83.00 to $65.00 in a research report on Thursday, May 19th. The Goldman Sachs Group reduced their price objective on Bath & Body Works from $85.00 to $61.00 and set a “buy” rating on the stock in a research report on Friday, May 20th. Telsey Advisory Group reduced their target price on shares of Bath & Body Works from $70.00 to $60.00 and set an “outperform” rating on the stock in a research note on Thursday, May 19th. Finally, Robert W. Baird dropped their price target on shares of Bath & Body Works from $75.00 to $65.00 and set an “outperform” rating for the company in a research note on Thursday, May 19th. Two research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $66.47.
Bath & Body Works Profile (Get Rating)
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Stories
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Get Rating).
Want More Great Investing Ideas?
Receive News & Ratings for Bath & Body Works Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bath & Body Works and related companies with MarketBeat.com’s FREE daily email newsletter.
